Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM) Given Average Recommendation of Buy by Analysts

Shares of Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM – Get Free Report) have been given a consensus recommendation of “Buy” by the five ratings firms that are currently covering the company, Marketbeat Ratings reports. Five analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokers that have issued a report on […]

Related Keywords

,Actinium Pharmaceuticals Company Profile ,Vanguard Group Inc ,Maxim Group ,Analyst Recommendations For Actinium Pharmaceuticals ,Northern Trust Corp ,Actinium Pharmaceuticals ,Blackrock Inc ,Geode Capital Management ,News Ratings For Actinium Pharmaceuticals Daily ,Actinium Pharmaceuticals Stock ,Cantor Fitzgerald ,Actinium Pharmaceuticals Inc ,Institutional Investors Weigh In On Actinium Pharmaceuticals ,Get Free Report ,Marketbeat Ratings ,Capital Management ,Street Corp ,Trust Corp ,Get Free ,Actinium Pharmaceuticals Daily ,